Decreased placental miR-126 expression and vascular endothelial growth factor levels in patients with pre-eclampsia

Journal of International Medical Research

Volumn 42, Issue 6, 2014, Pages 1243-1251

  Hong, Fanzhen ^a   Li, Yuyang ^a   Xu, Yongping ^a  

^a THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

Author keywords

miR 126; Pre eclampsia; real time RT PCR; vascular endothelial growth factor

Indexed keywords

MICRORNA 126; VASCULOTROPIN; BIOLOGICAL MARKER; MESSENGER RNA; MICRORNA; MIRN126 MICRORNA, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; ARTICLE; CHORIOCARCINOMA CELL LINE; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; PLACENTA; PREECLAMPSIA; PREGNANCY; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; CHORIOCARCINOMA; GENETICS; METABOLISM;

BIOLOGICAL MARKERS; CELLS, CULTURED; CHORIOCARCINOMA; FEMALE; HUMANS; MICRORNAS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84910598792     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060514540627     Document Type: Article

References (33)

1. Sibai B,Dekker G,Kupferminc M.Pre-eclampsia.Lancet. 2005;365:785-799
2. Myatt L.Role of placenta in preeclampsia.Endocrine. 2002;19:103-111
3. Mutter WP,Karumanchi SA.Molecular mechanisms of preeclampsia.Microvasc Res. 2008;75:1-8
4. Young BC,Levine RJ,Karumanchi SA.Pathogenesis of preeclampsia.Annu Rev Pathol. 2010;5:173-192
5. Powe CE,Levine RJ,Karumanchi SA.Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease.Circulation. 2011;123:2856-2869
6. George EM,Granger JP.Endothelin: key mediator of hypertension in preeclampsia.Am J Hypertens. 2011;24:964-969
7. Roberts JM,Redman CW.Pre-eclampsia: more than pregnancy-induced hypertension.Lancet. 1993;341:1447-1451
8. Cheung CY.Vascular endothelial growth factor: possible role in fetal development and placental function.J Soc Gynecol Investig. 1997;4:169-177
9. Torry DS,Torry RJ.Angiogenesis and the expression of vascular endothelial growth factor in endometrium and placenta.Am J Reprod Immunol. 1997;37:21-29
10. Zhou Q,Liu H,Qiao F, et al.VEGF deficit is involved in endothelium dysfunction in preeclampsia.J Huazhong Univ Sci Technolog Med Sci. 2010;30:370-374
11. Reuvekamp A,Velsing-Aarts FV,Poulina IE, et al.Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia.Br J Obstet Gynaecol. 1999;106:1019-1022
12. Cooper JC,Sharkey AM,Charnock-Jones DS, et al.VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia.Br J Obstet Gynaecol. 1996;103:1191-1196
13. Zhang C.MicroRNomics: a newly emerging approach for disease biology.Physiol Genomics. 2008;33:139-147
14. Urbich C,Kuehbacher A,Dimmeler S.Role of microRNAs in vascular diseases, inflammation, and angiogenesis.Cardiovasc Res. 2008;79:581-588
15. Bartel DP.MicroRNAs: genomics, biogenesis, mechanism, and function.Cell. 2004;116:281-297
16. Cheng W,Liu T,Jiang F, et al.microRNA-155 regulates angiotensin II type 1 receptor expression in umbilical vein endothelial cells from severely pre-eclamptic pregnant women.Int J Mol Med. 2011;27:393-399
17. Wang W,Feng L,Zhang H, et al.Preeclampsia up-regulates angiogenesis-associated microRNA (i.e., miR-17, -20a, and -20b) that target ephrin-B2 and EPHB4 in human placenta.J Clin Endocrinol Metab. 2012;97:E1051-E1059
18. Zhang Y,Diao Z,Su L, et al.MicroRNA-155 contributes to preeclampsia by down-regulating CYR61.Am J Obstet Gynecol. 2010;202:466.e1-466.e7
19. Zhang Y,Fei M,Xue G, et al.Elevated levels of hypoxia-inducible microRNA-210 in pre-eclampsia: new insights into molecular mechanisms for the disease.J Cell Mol Med. 2012;16:249-259
20. Hu Y,Li P,Hao S, et al.Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia.Clin Chem Lab Med. 2009;47:923-929
21. Wang S,Aurora AB,Johnson BA, et al.The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis.Dev Cell. 2008;15:261-271
22. Fish JE,Santoro MM,Morton SU, et al.miR-126 regulates angiogenic signaling and vascular integrity.Dev Cell. 2008;15:272-284
23. Uhlemann M,Möbius-Winkler S,Fikenzer S, et al.Circulating microRNA-126 increases after different forms of endurance exercise in healthy adults.Eur J Prev Cardiol. 2014;21:484-491
24. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002.Obstet Gynecol. 2002;99:159-167
25. Redman CW,Sargent IL.Latest advances in understanding preeclampsia.Science. 2005;308:1592-1594
26. Grill S,Rusterholz C,Zanetti-Dällenbach R, et al.Potential markers of preeclampsia–a review.Reprod Biol Endocrinol. 2009;7:70-70
27. Huppertz B.Placental origins of preeclampsia: challenging the current hypothesis.Hypertension. 2008;51:970-975
28. Choi SY,Yun J,Lee OJ, et al.MicroRNA expression profiles in placenta with severe preeclampsia using a PNA-based microarray.Placenta. 2013;34:799-804
29. Chen DB,Wang W.Human placental microRNAs and preeclampsia.Biol Reprod. 2013;88:130-130
30. Maynard SE,Min JY,Merchan J, et al.Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.J Clin Invest. 2003;111:649-658
31. Ferrara N.Vascular endothelial growth factor and the regulation of angiogenesis.Recent Prog Horm Res. 2000;55:15-35
32. Shore VH,Wang TH,Wang CL, et al.Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast.Placenta. 1997;18:657-665
33. Cirpan T,Akercan F,Terek MC, et al.Evaluation of VEGF in placental bed biopsies from preeclamptic women by immunohistochemistry.Clin Exp Obstet Gynecol. 2007;34:228-231